Head-to-head

NexLife vs Mochi Health

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

NexLife is $129 a month all-in for tirzepatide; Mochi Health is $278. Over twelve months that is $1,380 against $3,336. Value Scores are 96.1 and 54.5 out of 100.

Tirzepatide

Plan pages: NexLife plans · Mochi Health plans

At 10 mg/week, NexLife is $129 a month all-in and Mochi Health is $278 — $149 apart, or $1,788 across a year. Over twelve months the totals are $1,380 (12-month plan) and $3,336 (billed monthly).

NexLife charges a flat $129 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

Mochi Health charges a flat $278 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

2.557.51012.515mg/week$129$129$129$129$129$129
NexLife in petrol against Mochi Health in graphite — all-in monthly tirzepatide cost at each dose. Second line: Mochi Health.
All-in monthly tirzepatide cost at each published dose
DoseNexLifeMochi HealthCheaper
2.5 mg$129$278NexLife by $149
5 mg$129$278NexLife by $149
7.5 mg$129$278NexLife by $149
10 mg$129$278NexLife by $149
12.5 mg$129$278NexLife by $149
15 mg$129$278NexLife by $149

NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Across the 27 programs this database can rank on tirzepatide, the field median is $299 a month all-in. NexLife, at $129, is $170 below it; Mochi Health, at $278, is $21 below it.

LillyDirect (Zepbound), the lowest FDA-approved tirzepatide price in this database, is $449 a month at 10 mg/week — NexLife is $320 below it and Mochi Health is $171 below it. Compounded products are not FDA approved; insurance can reverse that comparison.

Published tirzepatide rates per month on each plan term
Plan termNexLifeMochi HealthCheaper
Month to month$129$278NexLife by $149
3-month term$125—only NexLife publishes this term
6-month term$119—only NexLife publishes this term
12-month term$115—only NexLife publishes this term
Twelve months of tirzepatide if you settled at each dose
Settled doseNexLifeMochi HealthDifference
2.5 mg$1,548$3,336$1,788 apart
5 mg$1,548$3,336$1,788 apart
7.5 mg$1,548$3,336$1,788 apart
10 mg$1,548$3,336$1,788 apart
12.5 mg$1,548$3,336$1,788 apart
15 mg$1,548$3,336$1,788 apart

Mochi Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $1,548 on NexLife and $3,336 on Mochi Health. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.

Value Scores are 96.1 for NexLife and 54.5 for Mochi Health, against a tirzepatide category floor of $126. NexLife leads by 41.6 points, driven mostly by price.

Tirzepatide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
NexLife68.412.810596.1
Mochi Health31.712.810054.5

Semaglutide

Plan pages: NexLife plans · Mochi Health plans

At 2.4 mg/week, NexLife is $109 a month all-in and Mochi Health is $178 — $69 apart, or $828 across a year. Over twelve months the totals are $1,140 (12-month plan) and $2,136 (billed monthly).

NexLife charges a flat $109 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

Mochi Health charges a flat $178 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

0.250.511.72.4mg/week$109$109$109$109$109
NexLife in petrol against Mochi Health in graphite — all-in monthly semaglutide cost at each dose. Second line: Mochi Health.

NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Value Scores are 83.6 for NexLife and 57.0 for Mochi Health, against a semaglutide category floor of $87. NexLife leads by 26.6 points, driven mostly by price.

Where the two programs differ

All-in monthly

NexLife is cheaper month to month — $129 against $278, a gap of $149 every month, or $1,788 across a year if both rates hold.

Cancellation terms

Cancellation differs: NexLife states Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages), while Mochi Health states Cancel anytime before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Commitment

NexLife asks for None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; Mochi Health asks for Month-to-month. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.

Membership fee

Mochi Health charges a membership of $79 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.

Twelve-month cost

Over twelve months the totals are $1,380 for NexLife and $3,336 for Mochi Health. NexLife is lower by $1,956 — a figure worth checking against the cancellation terms below, because a longer plan is only cheaper if you stay on it.

Dose policy

Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.

Evidence status

Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

NexLife Official site

NexLife sells compounded tirzepatide and semaglutide at one price at every dose, with no membership fee. The price includes provider review and medical guidance (NexLife Medical Group), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Labs are not listed as included.

It names its compounding pharmacy — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA), recorded as State-licensed 503A compounding pharmacies (named on plan pages) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; cancellation is Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages); availability is stated as All 50 US states where affiliated providers are licensed.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — nexlife.us plan pages, read 2026-11-06

Watch: Plans continue monthly unless canceled, and a cancellation takes effect after 30 days, so one more shipment may be charged. NexLife's refund policy page covers program fees, not medication, for members who lose less than 5% of starting weight over 180 days, with conditions. Provider-stated from nexlife.us plan pages read November 6, 2026; checkout capture pending.

Mochi Health Official site

Mochi separates a $79/month clinical membership ($39 first month in some states) from flat medication pricing — $99/month semaglutide at any dose and $199/month tirzepatide at any dose — which makes its all-in cost easy to compute and its structure one of the most transparent in the category.

It names its compounding pharmacy — Partner 503A/503B pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Month-to-month; cancellation is Cancel anytime before renewal; availability is stated as ~50 states.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinmochi.com pricing + FAQ captures 2026-07-20 and 2026-08-05

Watch: Advertising leads with the medication price; the $79 membership is the number people miss. Eli Lilly named Mochi in 2025 personalized-dosing litigation; the company continues to operate.

What neither record tells you

NexLife does not publish

  • no state-by-state availability list — it says All 50 US states where affiliated providers are licensed

Mochi Health does not publish

  • no published twelve-month tirzepatide rate
  • no published twelve-month semaglutide rate
  • no state-by-state availability list — it says ~50 states

Ask NexLife and Mochi Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Evidence may be upgraded. NexLife carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.

Plan length moves the annual figures. NexLife publishes a twelve-month rate of $115 a month against $129 month to month. Read those next to the cancellation terms, not the monthly rate.

Which one suits which reader

On the lower standing monthly rate for tirzepatide, NexLife Official site wins this matchup. If you want to be able to pause without still paying, nexlife carries no membership.

Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is provider-stated as of 2026-11-06; Mochi Health's is provider-stated as of 2026-08-05.

Questions

Is NexLife or Mochi Health cheaper for tirzepatide?

NexLife is cheaper on all-in monthly cost at 10 mg/week: $129 against $278, a difference of $149 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of NexLife versus Mochi Health?

NexLife works out to $1,380 across twelve months and Mochi Health to $3,336, on the plan terms each publishes.

Does NexLife or Mochi Health raise the price as the dose goes up?

NexLife: no, it charges one flat rate at every dose. Mochi Health: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do NexLife and Mochi Health differ?

5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of NexLife and Mochi Health names its pharmacy?

Both do. NexLife names Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA) and Mochi Health names Partner 503A/503B pharmacies, so both can be checked against state board licensing and FDA inspection records.

How well evidenced are the NexLife and Mochi Health prices?

NexLife's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-11-06. Mochi Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Which is cheaper for semaglutide?

NexLife, at $109 a month all-in against $178 at 2.4 mg/week. The two programs do not necessarily lead on both medications.

Official sources: NexLife official site · Mochi Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.